Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. The Company supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Classic way to develop !

Opsens still have ''Cash and cash equivalents at $23.8-million as of Aug. 31, 2022 and this  $ 5 M financing open the ''gate'' to expand the business world wise ! So this...read more

RE:secondary offering

The deal will close on december 22nd does it mean thawe are going back to 1.90$ until then?  rate and reply

secondary offering

Done at a big discount , $1.90 , to current price of $2.33. Does give the company more leeway as they begin commericalization  rate and reply

New Press Release - OPSENS INC. ANNOUNCES $10 MILLION BOUGHT DEAL OFFERING

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/QUÉBEC, Dec. 1, 2022/CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) announced today that it has...read article.

RE:Up 7.5% on the american market

It opened at US1.67 and has since added another 3 cents with a trading volume of 10.2K. Probably doesn't mean much but at least there are some US investors who are climbing aboard in anticipation...read more

Up 7.5% on the american market

on the OTCQX market Opsens is up 12 cents us or 7.5% i wonder if there is a meanig to that? GLTA  rate and reply

RE:RE:Q4 2022 revenues lower than Q3 2022

I guess we shouldn't be surprised by your latest post. And of course, we've had the New Zealand NR since this was posted but why would that change your view (assuming of course that you hold...read more

RE:RE:Top Gainers

We are going to see 1.8$ soon as there are a lot of panicking investors     rate and reply

RE:Top Gainers

So today we have the exact opposite. Very little volume so the SP is being walked down in small lots as a few investors panic and jump ship. GLTA  rate and reply

Top Gainers

And the 6th highest trading volume over the past 3 months. GLTA Symbol/ Company Price $ Change $ Volume Data delayed at least 15 minutes,...read more

RE:From Opsens’ LinkedIn:

Another success... Congratulations to Sunnybrook Hospital for joining the Sensor Guided TAVI revolution, completing their first #SavvyWire&trade; TAVI day with 4 cases! Thank you Dr. edgar...read more

RE:From Opsens’ LinkedIn:

Another success... Congratulations to Sunnybrook Hospital for joining the Sensor Guided TAVI revolution, completing their first #SavvyWire™ TAVI day with 4 cases! Thank you Dr. edgar hockmann, Dr...read more

From Opsens’ LinkedIn:

The first #SavvyWire cases in the Southeast US were completed today at Tallahassee Memorial HealthCare! Congratulations and thank you to Dr. Tom Noel, Dr. Pablo Rengifo-Moreno, Dr. Ed Ferguson and the...read more

RE:Only a Matter of Time

Predators must be looking at Opsens's expansion all around the globe . Why not Australia soon !  rate and reply

Only a Matter of Time

Before Savvywire is used throughout the world. Put this one away, relax and come back in a couple of years with a big smile on your face. All IMHO of course. GLTA The launch in New Zealand ...read more

New Press Release - OPSENS ANNOUNCES FIRST SAVVYWIRE(TM) PROCEDURE IN NEW ZEALAND

QUEBEC CITY, Nov. 29, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that Dr. Sanjeevan Pasupati, Director of Structural...read article.

This morning's La Presse _ Richard Dufour

Positive sentiment in spite of tweak in rating from Raymond James (my comment). Opsens fait toujours l’unanimit sur Bay Street, mais un analyste a ajust sa recommandation mardi aprs que l...read more

Stifel

Bargain basement price this morning. GLTA 09:18 AM EST, 11/25/2022 (MT Newswires) -- Stifel GMP on Friday reiterated its buy rating on the shares of Opsens (OPS.TO) and its C$3.75 price target...read more

RE:Hang on from. Raymond James see Opsens trimmed at $ 5,00

Still holding but a smaller position . Still believe a buyout is our best option to maximize our products . Glta  rate and reply